Plitidepsin information

Plitidepsin
Names
	Systematic IUPAC name (2S)-N-[(1R)-1-({(3S,6R,7S,10R,11S,15S,17S,20S,25aS)-10-[(2S)-Butan-2-yl]-11-hydroxy-3-[(4-methoxyphenyl)methyl]-2,6,17-trimethyl-20-(2-methylpropyl)-1,4,8,13,16,18,21-heptaoxo-15-(propan-2-yl)docosahydro-15H-pyrrolo[2,1-d] [10,19,1,4,7,14]dioxatetraazacyclotricosin-7-yl}carbamoyl)-3-methylbutyl]-N-methyl-1-(2-oxopropanoyl)pyrrolidine-2-carboxamide
	Other names Aplidine; Dehydrodidemnin B; Aplidin; N-[1-(1,2-Dioxopropyl)-L-prolyl]didemnin A
Identifiers
CAS Number	137219-37-5 ;
3D model (JSmol)	Interactive image;
ChEBI	CHEBI:90205;
ChEMBL	ChEMBL451930;
ChemSpider	26001665 ;
DrugBank	DB04977;
KEGG	D11032;
PubChem CID	9812534;
UNII	Y76ID234HW ;
CompTox Dashboard (EPA)	DTXSID0040418 ;
	InChI InChI=1S/C59H91N7O14/c1-15-35(8)50-47(69)30-49(71)80-53(34(6)7)52(72)37(10)54(73)60-41(26-32(2)3)58(77)65-24-16-18-42(65)48(70)31-63(12)44(29-39-20-22-40(79-14)23-21-39)46(68)28-36(9)51(56(75)61-50)62-55(74)45(27-33(4)5)64(13)59(78)43-19-17-25-66(43)57(76)38(11)67/h20-23,32-37,41-45,47,50-51,53,69H,15-19,24-31H2,1-14H3,(H,60,73)(H,61,75)(H,62,74)/t35-,36-,37-,41-,42-,43-,44-,45+,47-,50+,51-,53-/m0/s1 Key: RZFJKZZAZSUBCF-VETSTYKFSA-N ;
	SMILES O=C([C@@H](NC([C@@H](C)C([C@@H](OC(C[C@H](O)[C@H](NC([C@@H](NC([C@H](N(C([C@H]1N(C(C(C)=O)=O)CCC1)=O)C)CC(C)C)=O)[C@@H](C)OC([C@H](CC2=CC=C(OC)C=C2)N3C)=O)=O)[C@@H](C)CC)=O)C(C)C)=O)=O)CC(C)C)N4[C@H](C3=O)CCC4;
Properties
Chemical formula	C57H87N7O15
Molar mass	1110.357 g·mol−1
Pharmacology
ATC code	L01XX57 (WHO)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Plitidepsin (also known as dehydrodidemnin B, marketed by PharmaMar, S.A. under the trade name Aplidin) is a chemical compound extracted from the ascidian Aplidium albicans.^[1] It is currently undergoing clinical trial testing. It is a member of the class of compounds known as didemnins.

^ Newman DJ, Cragg GM (August 2004). "Marine natural products and related compounds in clinical and advanced preclinical trials". Journal of Natural Products. 67 (8): 1216–38. doi:10.1021/np040031y. PMID 15332835.

[1] Newman DJ, Cragg GM (August 2004). "Marine natural products and related compounds in clinical and advanced preclinical trials". Journal of Natural Products. 67 (8): 1216–38. doi:10.1021/np040031y. PMID 15332835.

Plitidepsin information

and 28 Related for: Plitidepsin information

Plitidepsin

Methotrexate

Tretinoin

Hydroxycarbamide

Carboplatin

Mitomycin C

Abemaciclib

Fluorouracil

Celecoxib

Venetoclax

Temozolomide

Vincristine

Cisplatin

Bortezomib

Olaparib

Oxaliplatin

Cyclophosphamide

Doxorubicin

Tebentafusp

Cytarabine

Azacitidine

Tisagenlecleucel

Exatecan

Nitrogen mustard

Arsenic trioxide

Alkylating antineoplastic agent

Navitoclax

Idecabtagene vicleucel